NIH Withdraws Renewal Grant Applications for Critically Important Eosinophilic Gastrointestinal Research (PRWeb)

The NIH’s abrupt dismissal of grant renewal applications for rare disease consortia — including the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) — is drawing sharp criticism from the AAAAI and patient advocacy groups. The decision, based on a minor technicality rather than scientific merit, threatens to dismantle critical research infrastructure and halt life-saving work for patients with eosinophilic gastrointestinal diseases. Advocates are urging Congress to intervene, warning that the move sets a dangerous precedent and will directly harm patient care and innovation.